← Back to Search

Intervention for Atrial Fibrillation (ALP Trial)

N/A

Waitlist Available

Led By Teddi Orenstein Lyall, MD

Research Sponsored by Teddi Orenstein Lyall

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline,1 year

Awards & highlights

ALP Trial Summary

The objectives of the investigators are to demonstrate a reduction in frequency and symptoms of AF and improvements in cardiovascular risk factors following a lifestyle intervention in patients with paroxysmal AF. Participants will be randomized into control or intervention groups. The intervention will receive step trackers, diet counselling, an exercise program, and risk factor modification consultations. Controls will receive step trackers and care as usual. Testing will occur at baseline, six months, and one year.

Eligible Conditions

Atrial Fibrillation

ALP Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline,1 year

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline,1 year

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline,1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Changes in Quality of Life on SF36

Changes in frequency of atrial fibrillation

Changes in severity of atrial fibrillation

Secondary outcome measures

Apnea hypopnea index

Body Mass Index

Pharmaceutical Preparations

+9 more

ALP Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: InterventionExperimental Treatment5 Interventions

Participants in the intervention group will receive risk factor management consultations and take part in 1-hour biweekly diet classes and stress management classes for the first 3 months. This will be followed by 3 months of 1-hour biweekly high intensity interval training exercise classes. At the 6-month time point, participants will be prescribed a home based exercise program and will have the option of participating in weekly group walking sessions. During the final 6 months, participants will use a step/activity tracker to track their steps and heart rate.

Group II: ControlActive Control1 Intervention

Participants in the control arm will receive standard care.

Do I qualify?Apply below to find out